Toggle navigation
Home
Search
Services
Blog
Contact
About
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P.
Stanford University, Stanford, CA, United States
Search 8 grants from Peggy Lu
Search grants from Stanford University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Phase II RCT of High-dose Vitamin D Supplements in Older Adults without Dementia
Recommendations and Interventions for and Changes in the Ocular Health and visual Function of Veterans with Traumatic Brain Injury
Training in Ophthalmic Statistical Genetics and Bioinformatics
Role of FOXO4 in atherosclerosis
Cancer Research Training in Radiation Sciences
Recently added grants:
Borrelia miyamotoi meningioencephalitis
Role of MIF in myeloma bone homing and drug response
Investigating the role of Nol3 in normal and malignant hematopoiesis
Development of a new molecular predictor for risk of distant metastases in melanoma
Symposium on Cognitive Auditory Neuroscience (SCAN)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA009324-02
Application #
2085280
Study Section
Immunology, Virology, and Pathology Study Section (IVP)
Project Start
1994-01-01
Project End
Budget Start
1994-01-01
Budget End
1994-12-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Related projects
NIH 1994
F32 CA
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P. / Stanford University
NIH 1992
F32 CA
Biology of Cytokine-Induced Killer Cells
Lu, Peggy P. / Stanford University
Publications
Lu, P H; Negrin, R S
(1994)
A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
J Immunol 153:1687-96
Comments
Be the first to comment on this grant